Syngenta Deal Could Pave Way for Biotech Acceptance From China Users | The New York Times

Print More

SINGAPORE — ChemChina’s purchase of Syngenta could remove some of the suspicion around genetically modified crops and ultimately lead to more rapid user acceptance of biotechnology in food production in China, Syngenta’s Chief Operating Officer Davor Pisk told Reuters.

Source: Syngenta Deal Could Pave Way for Biotech Acceptance From China Users | The New York Times

Leave a Reply

Your email address will not be published. Required fields are marked *